It is no secret that taking an in vitro diagnostic to market is hard.
And while this year’s BIO-Europe Spring event, held in Milan in March, focused primarily on cutting edge biotech and big...
Diagnostics Are Essential, But How Can Companies Ensure A Fair Price?
Biotech and pharma are increasingly clear about one thing: They need diagnostics. But with prices suppressed, how have diagnostics companies proven their utility without going under?
